Bank of New York Mellon Corp - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 75 filers reported holding KEMPHARM INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$977,365
-5.5%
202,773
-0.1%
0.00%
Q2 2023$1,034,704
+64.1%
202,883
+77.0%
0.00%
Q1 2023$630,444
+19.8%
114,6260.0%0.00%
Q4 2022$526,134
-28.7%
114,626
-3.0%
0.00%
Q3 2022$738,000
+40.0%
118,1660.0%0.00%
Q2 2022$527,000
-36.0%
118,166
-27.8%
0.00%
Q1 2022$823,000
+8.1%
163,617
+87.3%
0.00%
Q4 2021$761,000
-4.5%
87,344
+2.2%
0.00%
Q3 2021$797,000
-14.4%
85,454
+17.6%
0.00%
Q2 2021$931,00072,6450.00%
Other shareholders
KEMPHARM INC shareholders Q3 2021
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders